Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

746.74 +1.83 (+0.25%)
Official Closing Price Updated: 7:00 PM EST, Jan 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Biden Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs
The Biden Administration's proposal expands Medicare and Medicaid coverage for anti-obesity drugs, cutting costs for millions while addressing the obesity crisis. 
Via Benzinga
Eli Lilly Stock Is Rising Tuesday: What's Going On?
Eli Lilly And Co (NYSE:LLY) shares are trading higher Tuesday after the Biden-Harris Administration proposed a new rule to expand coverage of anti-obesity medications for Americans with Medicare and... 
Via Benzinga
Amgen Crashes 12% After Weight-Loss Drug Meets Eli Lilly's In A Key Test
Over the course of a year, Amgen's MariTide helped patients lose about 20% of their body weight. 
Via Investor's Business Daily
Thankful Investors - Last 5 Years
A look at the 25 best-performing stocks in the S&P 1500 on a total return basis over the last five years. 
Via Talk Markets
Topics Stocks Stocks / Equities
Exposures US Equities
(LLY) - Analyzing Eli Lilly's Short Interest
Via Benzinga
Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher, According to a Wall Street Analyst
Via The Motley Fool
Are Diet Drug Companies Over The Hump?
Eli Lilly made a reversal bottom low on Monday after a gap lower. Today’s price action was confirmation. 
Via Talk Markets
Topics Stocks / Equities
Is It Time to Sell Eli Lilly and Pfizer Stocks?
Via The Motley Fool
When It Is Too Late To Trade
Is it too late to get started with swing trading when considering the stock market rally, or should a new trader wait for a market crash or pullback? 
Via Talk Markets
Topics Stocks / Equities
Billionaire Israel Englander Increased His Stake In Eli Lilly During the Third Quarter: Should You?
Via The Motley Fool
Here's How Much You Would Need to Invest in This Unstoppable Vanguard ETF Today to Grow Your Portfolio to $1 Million or More by Retirement
Via The Motley Fool
Topics ETFs
2 Incredible Growth Stocks to Buy With $1,000 Right Now
Via The Motley Fool
Investing in Pharma Stocks? Check These 3 Things First
Via The Motley Fool
Weight-Loss Drugs Don't Seem To Impress RFK Jr. Should Eli Lilly, Novo Nordisk Investors Worry?
Robert F. Kennedy hasn't overtly commented on how he would handle GLP-1 drugs. But there are hints. 
Via Investor's Business Daily
Eli Lilly Unusual Options Activity
Via Benzinga
Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
LLY stock struggles, falling 16.85% over the last month due to bearish technicals and political uncertainty. But with projected sales and earnings growth, could this be a buying opportunity? 
Via Benzinga
Is Now a Good Time to Buy the Dip in Eli Lilly Stock?
Shares of Lilly are cratering, but investors may be surprised to learn what's influencing the volatility. 
Via The Motley Fool
Eli Lilly, Verge Genomics Opt To Develop ALS Drug Candidate
Eli Lilly and Verge Genomics advance ALS drug development with validated targets and a Phase 1B study, part of their $694 million collaboration since 2021. 
Via Benzinga
Big Pharma's Pharmacy-Benefit Managers Accuse FTC of Overreach In Effort to Reshape Drug Rebate System
PBMs Express Scripts, Caremark, and Optum challenge the FTC's administrative proceedings, arguing it violates constitutional rights and threatens the stability of drug pricing. 
Via Benzinga
LLY Stock Rebounds Amid AI-Driven ALS Research Breakthroughs
Verge Genomics and Eli Lilly have made significant progress in their collaboration to develop ALS treatments, identifying two promising drug targets using AI technology. 
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
Verge Genomics Announces Milestones in Collaboration with Lilly to Discover and Develop Novel Treatments for ALS
From Verge Genomics
Via GlobeNewswire
Top Research Reports For Eli Lilly, PepsiCo & Morgan Stanley
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Co., PepsiCo, Inc., and Morgan Stanley. 
Via Talk Markets
What To Do After The Worst Week For Healthcare Stocks Since March 2020?
The market was quiet today but we should still expect some gains through year -end albeit a bit choppy. 
Via Talk Markets
Eli Lilly Stock Eyes Worst Month Since February 2009: Is It Time To Buy The Dip?
Eli Lilly & Co. shares plunge 12.5% this month, worst since 2009, due to disappointing earnings and lowered guidance. The future remains uncertain. 
Via Benzinga
Eli Lilly's Investigational Drug Cuts Sticky Cholesterol Levels By Almost 86%
Eli Lilly's muvalaplin Phase 2 trial showed significant Lp(a) reduction, meeting primary and secondary endpoints with favorable safety data. 
Via Benzinga
Jim Cramer: Coinbase Is A 'Winner,' Suggests Buying This 'Hated' Big Pharma Stock
Jim Cramer recommends buying hated stock Eli Lilly, while also praising Coinbase and IES Holdings. Marvell and Apple are also solid bets. 
Via Benzinga
The Smartest Megacap Growth ETF to Buy With $500 Right Now
Via The Motley Fool
Topics ETFs
Eli Lilly's Zepbound/Mounjaro Shows Cardiovascular Benefits In Patients With Obesity-Related Heart Failure
Eli Lilly's Phase 3 SUMMIT trial results show tirzepatide's potential to reduce heart failure risk and improve symptoms in obese adults with HFpEF. 
Via Benzinga
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
Via The Motley Fool
If You Bought 1 Share of Eli Lilly in 1984, Here's How Many Shares You Would Own Now
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.